Replies to post #250729 on Biotech Values

[jbog]

Big Pharma is going to have to acquire substantial products to replace what's expiring the next 5 years


Top 10 drugs with patents due to expire in the next five years
Hannah Burke
16/02/2024

10 drugs that will expire with a total of $200B in Revenue



1. KEYTRUDA
Company: Merck & Co.
Key patent expiration: 2028

2. ELIQUIS
Company: Bristol Myers Squibb & Pfizer
Key patent expirations: 2027 to 2029

3. EYLEA
Company: Regeneron, Bayer
Key patent expirations: 2025 to 2026

4. OPDIVO
Company: Bristol Myers Squibb
Key patent expiration: 2028

5. IBRANCE
Company: Pfizer
Key patent expiration: 2027

6. XARELTO
Company: Bayer / J&J
Key patent expiration: 2026

7. TRULICITY
Company: Eli Lilly
Key patent expiration: 2027

8. PREVNAR 13
Company: Pfizer
Key patent expiration: 2026

9. OCREVUS
Company: Roche
Key patent expiration: 2028

10. PROLIA/XGEVA
Company: Amgen
Key patent expiration: 2025 to 2026




https://www.proclinical.com/blogs/2024-2/top-10-drugs-with-patents-due-to-expire-in-the-next-5-years#:~:text=Key%20patent%20expiration%3A%202028&text=Keytruda%20is%20on%20schedule%20to,%2433.7bn%20in%202028%20estimates.